Shandong Sanyuan Biotechnology Co.,Ltd. reported earnings results for the full year ended December 31, 2022. For the full year, the company reported sales was CNY 655.82 million compared to CNY 1,641.39 million a year ago. Revenue was CNY 674.91 million compared to CNY 1,675.32 million a year ago.

Net income was CNY 163.69 million compared to CNY 535.42 million a year ago. Basic earnings per share from continuing operations was CNY 0.82 compared to CNY 3.53 a year ago. Diluted earnings per share from continuing operations was CNY 0.82 compared to CNY 3.53 a year ago.